Diamond Clinic Sp. z o.o.
- Address
- lock Available on a paid plan
Respiratory Disease Research
At Diamond Medical Center in Cracow, clinical research in respiratory tract diseases focuses on asthma and the broader study of immune system processes involved in long-term disease control. The trials are designed to assess whether new treatments can improve safety, tolerability, and overall symptom management for people living with chronic airway disease.
- Evaluating the safety and tolerability of a new therapy for adult asthma
- Studying treatment effectiveness in people with moderate to severe respiratory disease
- Supporting better long-term management of chronic airway inflammation
This work reflects a strong interest in immune system diseases linked to breathing disorders, with a practical focus on improving outcomes for patients who need sustained treatment.
Dermatology and Immune-Mediated Skin Disease
Clinical trials at Diamond Clinic Sp. z o.o. also explore skin and connective tissue diseases, especially atopic dermatitis. These studies aim to determine whether new therapies can reduce symptoms, improve skin clearance, and offer better options for people with moderate to severe disease.
- Testing a potential new treatment for moderate to severe atopic dermatitis
- Measuring improvements in skin symptoms and disease control
- Assessing the value of treatment options for patients who have not used similar therapies before
The dermatology program highlights the site’s interest in immune-related skin inflammation and in finding more effective approaches for chronic, relapsing conditions.
Hair Loss and Dermatologic Innovation
Research in androgenetic alopecia adds another dermatology-focused area to the site’s portfolio. These trials are intended to evaluate whether emerging treatments can help slow hair loss and support visible hair regrowth in adult men affected by male pattern baldness.
- Assessing a treatment approach for male pattern hair loss
- Examining both efficacy and safety in adult participants
- Exploring new options for a common chronic skin-related condition
This line of research broadens the clinic’s work in skin and connective tissue diseases, with a clear emphasis on improving everyday quality of life through better cosmetic and clinical outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 15 of 53 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 50 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
- 1Eli Lilly & Co.4active
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.11trials
lock +8 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diamond Clinic Sp. z o.o.
lock Showing 1 of 49 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis | Almirall S.A. | Phase III | Not Recruiting | May 2023 | Apr 2026 |
IMP list
lock Showing 1 of 53 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 5 | Unknown | 2022-11-10 | 2024-10-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.